{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:58:03Z","timestamp":1781902683710,"version":"3.54.5"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/57\/2017"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/57\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.micpath.2021.105294","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T12:10:57Z","timestamp":1637064657000},"page":"105294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"PB","title":["Role of interleukin-17 in human papillomavirus infection and associated malignancies"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-0837","authenticated-orcid":false,"given":"Utkarsha","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5792-3082","authenticated-orcid":false,"given":"Prashant","family":"Khare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.105294_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00682","article-title":"Papillomavirus immune evasion strategies target the infected cell and the local immune system","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.micpath.2021.105294_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.micpath.2021.105294_bib3","first-page":"2","article-title":"Human papillomavirus (HPV), HPV-related disease, and the HPV vaccine","volume":"1","author":"Braaten","year":"2008","journal-title":"Rev. Obstet. Gynecol."},{"key":"10.1016\/j.micpath.2021.105294_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2021.105294_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib6","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1038\/ncomms6317","article-title":"Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients","author":"Kim","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2021.105294_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12967-015-0498-9","article-title":"Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years","author":"Paaso","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.micpath.2021.105294_bib8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/modpathol.2010.109","article-title":"Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression","volume":"23","author":"\u00d8vestad IT","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.micpath.2021.105294_bib9","series-title":"HPV Integration hijacks and Multimerizes a Cellular Enhancer to Generate a Viral-Cellular Super-Enhancer that Drives High Viral Oncogene Expression","volume":"14","author":"Warburton","year":"2018"},{"key":"10.1016\/j.micpath.2021.105294_bib10","first-page":"1","article-title":"Interleukin-17\u2014a multifaceted cytokine in viral infections","author":"Sahu","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.micpath.2021.105294_bib11","doi-asserted-by":"crossref","first-page":"190109","DOI":"10.1098\/rsob.190109","article-title":"The protective and pathogenic roles of IL-17 in viral infections: friend or foe?","volume":"9","author":"Ma","year":"2019","journal-title":"Open Biol."},{"key":"10.1016\/j.micpath.2021.105294_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.12688\/f1000research.10862.1","article-title":"Yin and yang of interleukin-17 in host immunity to infection","volume":"6","author":"Das","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.micpath.2021.105294_bib13","first-page":"9567","article-title":"Association between interluekin-17 gene polymorphisms and the risk of cervical cancer in a Chinese population","volume":"8","author":"Cong","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.micpath.2021.105294_bib14","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2217\/fmb.10.107","article-title":"Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies","volume":"5","author":"Graham","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2021.105294_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1099\/jgv.0.001105","article-title":"ICTV virus taxonomy profile: Papillomaviridae","volume":"99","author":"Van Doorslaer","year":"2018","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micpath.2021.105294_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/S0365-05962011000200014","article-title":"Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations","volume":"86","author":"Leto","year":"2011","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.micpath.2021.105294_bib17","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/JVI.77.8.4818-4826.2003","article-title":"Interactions between papillomavirus L1 and L2 capsid proteins","volume":"77","author":"Finnen","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2021.105294_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.micpath.2021.105294_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4939-2013-6_4","article-title":"HPV binding assay to Laminin-332\/integrin \u03b16\u03b24 on human keratinocytes","volume":"1249","author":"Brendle","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.micpath.2021.105294_bib20","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1074\/jbc.274.9.5810","article-title":"The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes","volume":"274","author":"Joyce","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2021.105294_bib21","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1073\/pnas.0508815103","article-title":"Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection","volume":"103","author":"Richards","year":"2006","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.micpath.2021.105294_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1155\/2007\/613150","article-title":"Papillomavirus life cycle organization and biomarker selection","volume":"23","author":"Doorbar","year":"2007","journal-title":"Dis. Markers"},{"key":"10.1016\/j.micpath.2021.105294_bib23","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1128\/JVI.72.10.8166-8173.1998","article-title":"A fifteen-amino-acid peptide inhibits human papillomavirus E1-E2 interaction and human papillomavirus DNA replication in vitro","volume":"72","author":"Kasukawa","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2021.105294_bib24","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4161\/cc.5.14.3094","article-title":"Partitioning viral genomes in mitosis: same idea, Different Targets","volume":"5","author":"McBride","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.micpath.2021.105294_bib25","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/jvi.69.5.2989-2997.1995","article-title":"Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells","volume":"69","author":"Jeon","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2021.105294_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2005.02.026","article-title":"Progression from productive infection to integration and oncogenic transformation in human papillomavirus type 59-immortalized foreskin keratinocytes","volume":"336","author":"Spartz","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2021.105294_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.micpath.2021.105294_bib28","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/jvi.65.5.2254-2260.1991","article-title":"Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation","volume":"65","author":"Bedell","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2021.105294_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/MMBR.68.2.362-372.2004","article-title":"Pathogenesis of human papillomaviruses in differentiating epithelia","volume":"68","author":"Longworth","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev. : MMBR (Microbiol. Mol. Biol. Rev.)"},{"key":"10.1016\/j.micpath.2021.105294_bib30","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3390\/ijms19061706","article-title":"High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis","volume":"19","author":"Yeo-Teh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2021.105294_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4143\/crt.2005.37.6.319","article-title":"The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis","volume":"37","author":"Yim","year":"2005","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.micpath.2021.105294_bib32","series-title":"Chapter 4 Replication and Partitioning of Papillomavirus Genomes. Advances in Virus Research","first-page":"155","author":"McBride","year":"2008"},{"key":"10.1016\/j.micpath.2021.105294_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2021.105294_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/infdis\/174.5.927","article-title":"The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women","volume":"174","author":"Carter","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.105294_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib36","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1128\/JVI.02151-15","article-title":"Downregulation of toll-like receptor 9 expression by beta human papillomavirus 38 and implications for cell cycle control","volume":"89","author":"Pacini","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2021.105294_bib37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.20122394","article-title":"The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter","volume":"210","author":"Hasan","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2021.105294_bib38","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","article-title":"Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity","volume":"12","author":"Ronco","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.micpath.2021.105294_bib39","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1074\/jbc.275.10.6764","article-title":"Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis","volume":"275","author":"Park","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2021.105294_bib40","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/ijc.25004","article-title":"All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization","volume":"126","author":"Cortese","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.micpath.2021.105294_bib41","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbrc.2006.08.182","article-title":"HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter","volume":"349","author":"Li","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2021.105294_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12885-019-5286-0","article-title":"Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins","volume":"19","author":"Khodabandehlou","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.micpath.2021.105294_bib43","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3892\/ol.2015.2884","article-title":"Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)","volume":"9","author":"Fernandes","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.micpath.2021.105294_bib44","first-page":"6215","article-title":"Th17 response in patients with cervical cancer (Review)","volume":"16","author":"Alves","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.micpath.2021.105294_bib45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"IL-17-producing cells: the sentinels of the immune system [published correction appears in Nat Rev Immunol. 2010 Jul;10(7):following 489]","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib46","first-page":"11100","article-title":"IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases","volume":"8","author":"Barnie","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.micpath.2021.105294_bib47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2021.105294_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.565470","article-title":"Much more than IL-17a: cytokines of the IL-17 family between microbiota and cancer","volume":"11","author":"Brevi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib50","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5114\/pdia.2014.40954","article-title":"Interleukin-17 in human inflammatory diseases","volume":"31","author":"Shabgah","year":"2014","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.micpath.2021.105294_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-030-38315-2_4","article-title":"IL-17 signaling in the tumor microenvironment","volume":"1240","author":"Gorczynski","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.micpath.2021.105294_bib52","doi-asserted-by":"crossref","unstructured":"Xue J, Wang Y, Chen C, Zhu X, Zhu H, Hu Y. Effects of Th17 cells and IL-17 in the progression of cervical carcinogenesis with high-risk human papillomavirus infection. Cancer Med..7:297-306.","DOI":"10.1002\/cam4.1279"},{"key":"10.1016\/j.micpath.2021.105294_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1746-1596-8-61","article-title":"The Th17\/Treg balance and the expression of related cytokines in Uygur cervical cancer patients","volume":"8","author":"Chen","year":"2013","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.micpath.2021.105294_bib54","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jocd.12472","article-title":"Possible role of interleukin-17 and macrophage migration inhibitory factor in cutaneous warts","volume":"17","author":"El-Hamd MA","year":"2018","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.micpath.2021.105294_bib55","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","article-title":"Interleukin-17 promotes angiogenesis and tumor growth","volume":"101","author":"Numasaki","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2021.105294_bib56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-2478(99)00042-5","article-title":"Control of tumor development by intratumoral cytokines","volume":"68","author":"Pages","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2021.105294_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pros.10238","article-title":"Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate","author":"Steiner","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.micpath.2021.105294_bib58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/bbrc.2001.4618","article-title":"Expression of IL-17 mRNA in ovarian cancer","volume":"282","author":"Kato","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2021.105294_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ijc.20373","article-title":"Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome)","volume":"112","author":"Cir\u00e9e","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.micpath.2021.105294_bib60","first-page":"3698","article-title":"Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice","volume":"59","author":"Tartour","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.micpath.2021.105294_bib61","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.4049\/jimmunol.1400216","article-title":"IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia","volume":"193","author":"Gosmann","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13027-015-0005-1","article-title":"IL-10, IL-15, IL-17, and GMCSF level in cervical cancer tissue of Tanzanian women infected with HPV16\/18 vs. non-HPV16\/18 genotypes","volume":"10","author":"Vidal","year":"2015","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.micpath.2021.105294_bib63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archotol.133.7.705","article-title":"Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis","volume":"133","author":"Erbek","year":"2007","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.micpath.2021.105294_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.aott.2017.11.002","article-title":"Proinflammatory biomarkers' level and functional genetic polymorphisms in periprosthetic joint infection","volume":"52","author":"Erdemli","year":"2018","journal-title":"Acta Orthop. Traumatol. Turcica"},{"key":"10.1016\/j.micpath.2021.105294_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12985-019-1187-8","article-title":"Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A\/H1N1 and B in an Iranian population","volume":"16","author":"Keshavarz","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2021.105294_bib66","doi-asserted-by":"crossref","first-page":"20439","DOI":"10.1038\/srep20439","article-title":"Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: an updated meta-analysis","volume":"6","author":"Dai","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2021.105294_bib67","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/gtmb.2016.0177","article-title":"Polymorphisms in the IL-17 gene (rs2275913 and rs763780) are associated with hepatitis B virus infection in the han Chinese population","volume":"21","author":"Ren","year":"2017","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.micpath.2021.105294_bib68","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1002\/cncr.25224","article-title":"Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer","volume":"116","author":"Chang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.micpath.2021.105294_bib69","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.micpath.2021.105294_bib70","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cell.2014.03.006","article-title":"The fire within: microbes inflame tumors","volume":"157","author":"Gagliani","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2021.105294_bib71","doi-asserted-by":"crossref","first-page":"436307","DOI":"10.1155\/2013\/436307","article-title":"Interleukin-17: a promoter in colorectal cancer progression","volume":"2013","author":"Wu","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib72","article-title":"Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 level in patients with colorectal cancer","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2021.105294_bib73","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.micpath.2021.105294_bib74","first-page":"3214","article-title":"Human papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 expression in patients with breast cancer","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.micpath.2021.105294_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2021.105294_bib76","first-page":"19","article-title":"The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus","volume":"7","author":"Leechanachai","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.micpath.2021.105294_bib77","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/jvi.69.5.3185-3192.1995","article-title":"The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes","volume":"69","author":"Straight","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2021.105294_bib78","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1074\/jbc.M110.199190","article-title":"Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression","volume":"286","author":"Heller","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2021.105294_bib79","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1159\/000484390","article-title":"IL-17 activates the IL-6\/STAT3 signal pathway in the proliferation of hepatitis B virus-related hepatocellular carcinoma","volume":"43","author":"Hu","year":"2017","journal-title":"Cell. Physiol. Biochem. : Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.micpath.2021.105294_bib80","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11882-013-0361-0","article-title":"Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders","volume":"13","author":"Robinson","year":"2013","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.micpath.2021.105294_bib81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-016-0031-5","article-title":"Secukinumab: a new treatment option for psoriatic arthritis","volume":"3","author":"Mease","year":"2016","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.micpath.2021.105294_bib82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13075-020-02208-w","article-title":"Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis","volume":"22","author":"Yin","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.micpath.2021.105294_bib83","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.micpath.2021.105294_bib84","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2021.105294_bib85","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1358\/dot.2017.53.5.2613690","article-title":"Brodalumab: the first anti-IL-17 receptor agent for psoriasis","volume":"53","author":"Puig","year":"2017","journal-title":"Drugs Today"},{"key":"10.1016\/j.micpath.2021.105294_bib86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cellimm.2005.11.002","article-title":"Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis","volume":"237","author":"Hofstetter","year":"2005","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02307","article-title":"An ROR\u03b3t oral inhibitor modulates IL-17 responses in peripheral blood and intestinal mucosa of crohn's disease patients","volume":"9","author":"Bassolas-Molina","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.105294_bib88","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/all.12937","article-title":"STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model","volume":"71","author":"Gavino","year":"2016","journal-title":"Allergy"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021005684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021005684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:41:44Z","timestamp":1781901704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021005684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":88,"alternative-id":["S0882401021005684"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105294","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of interleukin-17 in human papillomavirus infection and associated malignancies","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105294"}}